To understand if this mechanism could underlie the reduced patient survival seen in ccRCC cases with high FOXD1 tumor expression (Fig. 1a), we performed a correlation analysis between FOXD1 expression in ccRCC tumors and biological pathways. The gene discussed is FOXD1; the disease is nonpapillary renal cell carcinoma.